Promoting and facilitating strategies to improve cardiovascular health worldwide







Meeting Highlights

From the 26th Annual Scientific Meeting of the ISCP – Singapore



Tratamiento con ACOD en pacientes con FA post-ICP

ISCP On-Demand Webinar



ISCP Webinar: Cardiovascular Risk Management of Diabetes and SGLT2 Inhibitors



Exercising in the morning could reduce CVD risk

Posted on December 03, 2022

The timing of physical activity could affect the risk for CVD, according to study findings published in the European Journal of Preventive... more

Fatty pancreas increases diabetes risk, but may be reversible with weight loss

Posted on December 02, 2022

Adults with an elevated level of pancreatic fat have higher risk for developing incident diabetes, but weight loss may be able to... more

‘No time to waste’: Implement guideline-recommended HF therapies simultaneously

Posted on December 02, 2022

The benefits of HF medications are additive and incremental and provide similar benefits to patients with ischemic and nonischemic etiologies when initiated... more

Patients often misunderstand common medical phrases

Posted on December 02, 2022

Patients frequently misunderstand physician phrases and assign opposite meanings of what was intended, leading to confusion about health outcomes, a study published... more

ISCP book series

Current Cardiovascular Therapy
Kaski, Juan Carlos.

Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...

  • Antiplatelet and Anticoagulation Therapy

    A. Ferro, D.A. Garcia (Eds.)

  • Pharmacological Treatment of Acute Coronary Syndromes

    Avanzas, Pablo; Clemmensen, Peter(Eds.)

  • Atrial Fibrillation Therapy

    Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)

board of directors

Providing a leadership and advocacy role amongst members of their national societies.


  •   Thomas Kahan


    Affiliations/Memberships Professor of Medicine Department of Clinical Sciences, Danderyd Hospital Division of Cardiovascular Medicine (more…) more

  •   Pablo Avanzas


    Affiliations/Memberships Consultant in Invasive Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain Fellow of (more…) more

  •   Sang Hong Baek

    VP/President Elect

    Professor Sang Hong Baek is Director of Heart Failure and Transplantation Programme and Preventive Cardiology at Seoul St. Mary's (more…) more

  •   Georg Noll


      Georg Noll is a specialist in General Internal Medicine and Cardiology at Heart Clinic Zurich. He was Associate Professor of Cardiology (more…) more